Category: Uncategorized

Protected: YAFO Client | Breakthrough for Next-Generation TRK Inhibitor: Jiangsu Vcare’s New Anti-tumor Drug, Eratrectinib (VC004) Capsules, Receives NDA Acceptance

Vol.56, 2025 YAFO Weekly Global Wrap-up Report 雅法全球生物医药交易周报

Vol.55, 2025 YAFO Weekly Global Wrap-up Report 雅法全球生物医药交易周报

The ACCESS CHINA BD Forum @ BIO Concludes with Resounding Success

Ranok to Speak at ACCESS CHINA BD Forum @ BIO

Virion Therapeutics to Speak at ACCESS CHINA BD Forum @ BIO